Proscizen’s commitment to extend science-led high-quality research services reflects from the involvement and close oversight of our executive leadership in every task we undertake so that it meets the stated objectives of a clinical program in a timely manner. Every project we manage has to undergo a close review of our senior management including our President Dr Sumant Khanna.
restonite reviews 50 rimonabant acomplia reviews cheap buy or order a paper in the flagyl no prescription flagyl antibiotic side effects drug avelox 400mg moxifloxacin drugsВ Dr Sumant Khanna can prednisone help with tmj pain cheap online antibotic fastest delivery 40 mg online order setraline without prescription lincocin injection 600mg
(CEO and President)
Dr Khanna is among the pioneers of clinical research industry in India and globally. With almost 30 years of experince in all spheres of managing global clinical programs Dr Khanna has been a key contributor behind the success of global clinical programs of multinational bio-pharmaceutical sponsors. He has been a lead investigator for protocols which included responsibilities of submitting final study reports to FDA and other international regulatory agencies. Additionally he was a principal investigator and co-investigator for many trials which were sponsored by large multinational pharmaceutical companies. He has been responsible for setting up some of the initial clinical infrastructure and research bodies in India like the first biological psychiatry laboratory in India and the first OCD Clinic in India at National Institute of Mental Health and Sciences Bangalore, and the Clinical Psychopharmacology Research Group. He has been a guide for DNB, MD and PhD students and has authored/co-authored more than 200 publications in peer reviewed international journals. He has participated in more than 100 international conferences where he has presented in capacities as a subject matter expert, as a scientist, as a clinical researcher, as a key opinion leader and as a thought leader propagating best practices on managing clinical trials in India. These presentations have attracted a wide audience from the industry across the globe. Dr Khanna has consulted multinational pharmaceutical companies and CROs like Quintiles, has been a medical monitor on international trials and has attended investigator meetings which included discussions on protocols. He has been actively involved in Protocol design, review, feasibility assessments and periodic review of trials which included taking corrective measures. Additionally he has been involved in Data Safety Monitoring and Relapse Monitoring Boards, Ethics Committees, and as a rater trainer (including training on scales and inter rater reliability assessments). His trainings have been attended by US and EU based researchers and well appreciated. He was the first president of a start up CRO from India and successfully led the company to a size of more than 100 associates from less than 10 when he joined. Supported by his credentials in ethical and scientific conduct of clinical programs and his deep personal involvement in every project, sponsors had also selected that CRO as a lead full service CRO for certain global clinical studies.
Dr Khanna is committed to personally review and provide his oversight to every trial we manage in whatsoever capacity.
.